Michelle Hall
speaker
59 appearances
1 recordings
1 series
first heard Jul 2026
last heard 3 Jul
Michelle Hall’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Jul 2026 with 1.
Appearances
Right.
I can't say that I recall it.
Is that my nightmare?
That's right.
I think, generally speaking, melatonin is...
what we call, you know, quite a low risk option.
You know, it doesn't seem to be associated with what we'd be really concerned about, severe adverse effects.
So in that terms, it's got a quite a good profile.
And, you know, it is available over the counter here.
And it is available in other countries at greater dosage as well.
So at this moment, at this period of time where we looked at, I think there's about three months post intake,
you wouldn't be too concerned about the side effects and that's probably one of the more exciting findings.
What we can do is sort of talk about what we found with studies that look at melatonin and then look at studies that look at paracetamol.
And we see that the benefits on pain is quite, it's comparable.
So that's what we would say an indirect comparison, but we've never compared them head to head.
Yeah, we're quietly optimistic that we will see signals, at least in some patients, that by targeting their poor sleep, as well as helping them get physically active, that we will do better than just either of those alone.
Michelle, thank you very much.
My pleasure.
Thanks so much for having me.
Showing 41–59 of 59 · page 3 of 3
← Previous